Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Prostate cancer treatment is advancing rapidly. New pills and hormone treatments are giving patients better odds and a more comfortable experience. Doctors say Biden's diagnosis is a reminder to get ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

A clinical trial at BC Cancer Victoria using artificial intelligence (AI) is reducing the number of radiation treatments to ...

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

A groundbreaking study at Rabin Medical Center suggests prostate cancer patients may need only two radiation doses, ...

A novel, cooled laser focal therapy (cLFT) exhibits high treatment success for localized prostate cancer (PCa), accord ...

When you’re diagnosed with prostate cancer at an early stage, usually stage I or II, it means the disease hasn't spread outside your prostate gland. That means you have a few good treatment options to ...